Breathe Well Live Well
|
Vectura Inks Asthma/COPD License Agreement with Janssen
Genetic Engineering & Biotechnology News Vectura, a respiratory product development company, has entered a license agreement with Janssen Biotech to exclusively develop anti-inflammatory therapies for the treatment of asthma/COPD. The collaboration will initially focus on the development of a … |
View full post on asthma – Google News
|
Teijin Pharma inks bronchial asthma pact with Pulmagen
Pharma Times The number of people in Japan suffering from bronchial asthma has nearly doubled to more than eight million adults and children over the past 10 years. Although mortality is declining, more than 2,000 people, mainly elderly, still die from the … Japan,United Kingdom : Teijin Pharma and Pulmagen Therapeutics Sign … Teijin to develop and market bronchial asthma drug in Japan |
View full post on asthma – Google News